Today: 21 December 2025
Subscribe
Browse Category

Investment Analysis News 11 December 2025

EchoStar (SATS) Stock News and Forecast After November 21, 2025: SpaceX Deal, AT&T Spectrum and Analyst Targets

EchoStar (SATS) Stock News and Forecast After November 21, 2025: SpaceX Deal, AT&T Spectrum and Analyst Targets

EchoStar Corporation (NASDAQ: SATS) has gone from near‑distress to one of 2025’s hottest and most controversial telecom stocks, riding massive spectrum deals with SpaceX and AT&T and fresh buzz around a potential SpaceX IPO in 2026. Since November 21, 2025,
11 December 2025
 ·  ·  ·  ·  ·  · 
Lam Research (LRCX) Stock Near Record High After Oregon Expansion and AI Chip Boom: Price Targets, Forecasts and Risks

Lam Research (LRCX) Stock Near Record High After Oregon Expansion and AI Chip Boom: Price Targets, Forecasts and Risks

As of December 11, 2025, Lam Research Corporation (NASDAQ: LRCX) is trading near record highs after a year‑long surge powered by artificial‑intelligence (AI) chip demand and a fresh expansion in Oregon’s “Silicon Forest.” The stock recently pushed into the high‑$160s,
11 December 2025
 ·  ·  ·  ·  · 
Vertiv (VRT) Stock Pulls Back After Wolfe Downgrade – Can the AI Data Center Winner Keep Climbing in 2026?

Vertiv (VRT) Stock Pulls Back After Wolfe Downgrade – Can the AI Data Center Winner Keep Climbing in 2026?

Vertiv Holdings Co (NYSE: VRT), one of Wall Street’s favorite “picks-and-shovels” plays on artificial intelligence and data centers, is taking a breather after a huge multi‑year run. As of midday trading on December 11, 2025, Vertiv shares were changing hands
11 December 2025
 ·  ·  ·  ·  · 
Affirm Holdings (AFRM) Stock on December 11, 2025: Shopify Expansion, Institutional Buying and Lofty Price Targets Put BNPL Leader Back in Focus

Affirm Holdings (AFRM) Stock on December 11, 2025: Shopify Expansion, Institutional Buying and Lofty Price Targets Put BNPL Leader Back in Focus

As of December 11, 2025, Affirm Holdings, Inc. (NASDAQ: AFRM) is once again one of the most closely watched names in fintech. The buy now, pay later (BNPL) pioneer has turned the corner into profitability, deepened its global partnership with
11 December 2025
 ·  ·  ·  ·  · 
Arrowhead Pharmaceuticals (ARWR) Stock Near 52‑Week High After FDA Approval and New Alzheimer’s Trial: Latest News & Forecasts as of December 11, 2025

Arrowhead Pharmaceuticals (ARWR) Stock Near 52‑Week High After FDA Approval and New Alzheimer’s Trial: Latest News & Forecasts as of December 11, 2025

Arrowhead Pharmaceuticals (NASDAQ: ARWR) has quietly turned into one of 2025’s wildest biotech comeback stories. After years as a perpetually “promising” RNA interference (RNAi) platform, the company now has: The stock price has responded in full drama mode. As of
11 December 2025
 ·  ·  ·  · 
Snowflake (SNOW) Stock Outlook After November 21, 2025: AI Deals, Legal Risks and Price Targets to 2030

Snowflake (SNOW) Stock Outlook After November 21, 2025: AI Deals, Legal Risks and Price Targets to 2030

As of December 11, 2025, Snowflake Inc. (NYSE: SNOW) sits right at the intersection of three powerful storylines: explosive AI demand, nervousness about profit margins, and mounting legal and regulatory risk. Since November 21, 2025, those threads have come together
11 December 2025
 ·  ·  ·  ·  · 
1 … 59 60 61 62 63 … 159
Go toTop